✦ LIBER ✦

A Clinical Randomized Trial to Evaluate the Safety of a Noninvasive Approach in High-Risk Patients Undergoing Major Vascular Surgery: The DECREASE-V Pilot Study

✍ Scribed by Don Poldermans; Olaf Schouten; Radosav Vidakovic; Jeroen J. Bax; Ian R. Thomson; Sanne E. Hoeks; Harm H.H. Feringa; Martin Dunkelgrün; Peter de Jaegere; Alexander Maat; Marc R.H.M. van Sambeek; Miklos D. Kertai; Eric Boersma

Book ID: 119266498
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 446 KB
Volume: 49
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2006.11.052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Outcome of Prophylactic Corona

Long-Term Outcome of Prophylactic Coronary Revascularization in Cardiac High-Risk Patients Undergoing Major Vascular Surgery (from the Randomized DECREASE-V Pilot Study)

✍ Olaf Schouten; Jan-Peter van Kuijk; Willem-Jan Flu; Tamara A. Winkel; Gijs M.J.M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Long-Term Outcome of Prophylactic Corona

Long-Term Outcome of Prophylactic Coronary Revascularization in Cardiac High-Risk Patients Undergoing Major Vascular Surgery (from the randomized DECREASE-V pilot study)

✍ O. Schouten; J.P. van Kuijk; W.J. Flu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

✍ Rajendra H. Mehta; John H. Alexander; Robert Emery; Stephen J. Ellis; Vic Hassel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 209 KB

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views